Out of stock

This item is currently unavailable

The 2025-2030 World Outlook for Peptides and Heparin for Diabetes

Out of stock

Price data last checked 24 day(s) ago - will refresh soon

View at Amazon

One email. No newsletter. No nudges.

Gone for 227 days. Could come back at any time — we're watching for you.

Out of stock 227 days · last price £790 · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 669 days · 669 data points (no recent data)

Historical
Generating forecast…
£790.00 £750.50 £766.30 £782.10 £797.90 £813.70 £829.50 01 September 2024 15 February 2025 01 August 2025 15 January 2026 01 July 2026

Price Distribution

Price distribution over 669 days • 1 price levels

Days at Price
669 days 0 167 335 502 669 £790 Days at Price

Price Analysis

Most common price: £790 (669 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 669 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
28 April 2024

Similar Products You Might Like

The 2023-2028 Outlook for Peptides and Heparin for Diabetes in Japan
99% match

The 2023-2028 Outlook for Peptides and Heparin for Diabetes in Japan

£495.00 21 Jun 2026
The 2023-2028 Outlook for Peptides and Heparin for Diabetes in India
98% match

The 2023-2028 Outlook for Peptides and Heparin for Diabetes in India

£515.00 26 Jun 2026
The 2023-2028 Outlook for Peptides and Heparin for Diabetes in the United States
98% match

The 2023-2028 Outlook for Peptides and Heparin for Diabetes in the United States

£520.00 24 Jun 2026
The 2023-2028 Outlook for Peptides and Heparin for Diabetes for US Zip Codes
98% match

The 2023-2028 Outlook for Peptides and Heparin for Diabetes for US Zip Codes

£490.00 26 Jun 2026
The 2026-2031 World Outlook for Unfractionated Heparin
97% match

The 2026-2031 World Outlook for Unfractionated Heparin

£885.00 06 Jul 2026
The 2025-2030 World Outlook for Heparin
97% match

The 2025-2030 World Outlook for Heparin

Price unavailable
The 2025-2030 World Outlook for Heparin Anticoagulants
97% match

The 2025-2030 World Outlook for Heparin Anticoagulants

Price unavailable
The 2025-2030 World Outlook for Unfractionated Heparin
97% match

The 2025-2030 World Outlook for Unfractionated Heparin

Price unavailable
The 2025-2030 World Outlook for Crude Heparin
96% match

The 2025-2030 World Outlook for Crude Heparin

Price unavailable
The 2023-2028 World Outlook for Heparin Anticoagulants
96% match

The 2023-2028 World Outlook for Heparin Anticoagulants

Price unavailable
The 2023-2028 World Outlook for Heparin
96% match

The 2023-2028 World Outlook for Heparin

Price unavailable
The 2023-2028 Outlook for Unfractionated Heparin in the United States
96% match

The 2023-2028 Outlook for Unfractionated Heparin in the United States

£520.00 26 Jun 2026
The 2023-2028 World Outlook for Unfractionated Heparin
96% match

The 2023-2028 World Outlook for Unfractionated Heparin

£795.00 16 Jun 2026
The 2023-2028 Outlook for Unfractionated Heparin in India
96% match

The 2023-2028 Outlook for Unfractionated Heparin in India

£515.00 23 Jun 2026
The 2016-2021 Outlook for Insulins and Anti-Diabetic Hormones and Synthetic Substitute Pharmaceuticals in the United States
96% match

The 2016-2021 Outlook for Insulins and Anti-Diabetic Hormones and Synthetic Substitute Pharmaceuticals in the United States

£595.00 01 Jul 2026
The 2016-2021 Outlook for Insulins and Anti-Diabetic Hormones and Synthetic Substitute Pharmaceuticals in India
96% match

The 2016-2021 Outlook for Insulins and Anti-Diabetic Hormones and Synthetic Substitute Pharmaceuticals in India

£595.00 29 Jun 2026
The 2025-2030 World Outlook for Heparin Sodium
96% match

The 2025-2030 World Outlook for Heparin Sodium

Price unavailable
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in the United States
96% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in the United States

£495.00 12 Jun 2026
The 2025-2030 World Outlook for Next Generation Diabetes Therapy and Drug Deliveries
96% match

The 2025-2030 World Outlook for Next Generation Diabetes Therapy and Drug Deliveries

Price unavailable
The 2016-2021 Outlook for Low Molecular Weight Heparin (LMWH) in the United States
96% match

The 2016-2021 Outlook for Low Molecular Weight Heparin (LMWH) in the United States

£595.00 10 Jun 2026
The 2016-2021 Outlook for Low Molecular Weight Heparin (LMWH) in Greater China
96% match

The 2016-2021 Outlook for Low Molecular Weight Heparin (LMWH) in Greater China

£595.00 10 Jul 2026
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in India
96% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in India

£495.00 12 Jun 2026
The 2026-2031 World Outlook for Smart Insulin Pens and Pumps
96% match

The 2026-2031 World Outlook for Smart Insulin Pens and Pumps

£885.00 25 Jun 2026
The 2016-2021 Outlook for Low Molecular Weight Heparin (LMWH) in Japan
96% match

The 2016-2021 Outlook for Low Molecular Weight Heparin (LMWH) in Japan

£595.00 10 Jul 2026